Impella CP Improves Survival in STEMI, Cardiogenic Shock
Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.
Stay updated with breaking news from Vascular Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.
Vifor Pharma and partner Travere Therapeutics on Friday won an endorsement for approval from the European Union's drug regulator for their drug Filspari, part of an industry...
A post hoc analysis suggested that thiamine supplementation improved renal replacement therapy-free survival in patients with septic shock.
Patients who underwent amputation due to a diabetic foot event had a greater risk for early death regardless of the presence or absence of ulcers or gangrene before the amputation.
New research backed up previous findings, showing a substantially higher risk for severe hypocalcemia in older patients on kidney dialysis than in those treated with oral bisphosphonates.